COMMUNIQUÉS West-GlobeNewswire

Alcobra Announces Third Quarter 2017 Financial Results and Provides Corporate Update

09/11/2017 - 13:00

TEL AVIV, Israel, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Alcobra Ltd. (NasdaqGM:ADHD) today announced financial results for the three and nine months ended September 30, 2017, and provided a corporate update. Third Quarter [...]

ProQR Appoints Thaddeus Dryja, M.D. to Scientific Advisory Board

09/11/2017 - 13:00

Key Updates Dr. Thaddeus (Ted) Dryja, a pioneer in the field of retinal genetic diseases, joins the Company’s Scientific Advisory Board. Dr. Dryja will play a key strategic role in the development and advancement of [...]

Purepoint Uranium Acquires Additional Claims, Tripling the Size of McArthur East Project

09/11/2017 - 12:45

TORONTO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Purepoint Uranium Group Inc. (the “ Company ” or “ Purepoint ”) (TSX-V: PTU ) today reported the staking of 6 new claims adjacent to their 100% owned McArthur East project, [...]

Histogenics Corporation Announces Third Quarter 2017 Financial and Operating Results

09/11/2017 - 12:30

Top-line, 1-year Superiority Data for NeoCart ® Phase 3 Clinical Trial and Potential Biologics License Application Filing Remain on Track for Third Quarter of 2018 Company to Host Conference Call and Webcast Thursday, [...]

Epizyme to Present at the Jefferies 2017 London Healthcare Conference

09/11/2017 - 12:30

CAMBRIDGE, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ: EPZM ), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that management will present a company [...]

INC Research/inVentiv Health Reports Third Quarter 2017 Results

09/11/2017 - 12:20

Highlights Net service revenue of $592.2 million and $1,102.4 million for the three and nine months ended September 30, 2017, respectively. Combined Company adjusted net service revenue of $766.6 million and $2,331.6 [...]

Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference

09/11/2017 - 12:00

JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT ), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, [...]

iSalus Healthcare Opens New Office in Downtown Indianapolis

09/11/2017 - 12:00

INDIANAPOLIS, Nov. 09, 2017 (GLOBE NEWSWIRE) -- iSalus Healthcare, a premier healthcare technology and services company in Indiana, has recently moved offices to 1 Virginia Avenue, Suite 500, Indianapolis, IN 46204 . [...]

Helius Medical Technologies Announces Positive Results from its Registrational Clinical Trial for Traumatic Brain Injury (TBI)

09/11/2017 - 12:00

NEWTOWN, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (OTCQB:HSDT) ("Helius" or the "Company"), a medical technology company focused on neurological wellness, announced results [...]

RadNet Reports Third Quarter Financial Results and Reaffirms Previously Announced 2017 Guidance Levels

09/11/2017 - 12:00

Total Net Revenue (“Revenue”) increased 1.3% to $227.6 million in the third quarter of 2017 from $224.6 million in the third quarter of 2016: Adjusting for the sale of the Rhode Island facilities, Revenue increased 1.9 [...]

Crown Bioscience Inc. Announcing the 2017 Board of Directors Election Results

09/11/2017 - 11:21

TAIPEI, Taiwan, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company providing [...]

Ossur Hf : Management Changes

09/11/2017 - 11:01

Announcement Össur hf. No. 81/2017 Reykjavik, 9 November 2017 New R&D leadership Dr. Thorvaldur Ingvarsson, EVP of Research & Development (R&D), has decided to leave Össur after leading the R&D function [...]

Share Capital and Votes

09/11/2017 - 09:21

Pursuant to section 10 of executive order no. 1526 of December 9, 2016 on Issuers' Disclosure Obligations, it is hereby announced, that BioPorto A/S total share capital amounts to DKK 155.509.681 divided into shares of [...]

Bavarian Nordic Announces Initiation of Phase 2 Booster Study of its Universal RSV Vaccine

09/11/2017 - 07:32

Study to help determine if MVA-BN RSV will be administered as a seasonal vaccine or if a single shot is effective for multiple seasons COPENHAGEN, Denmark, November 9, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) [...]

VALNEVA publie une très forte performance opérationnelle sur les neufs premiers mois de l'exercice 2017

09/11/2017 - 07:02

Valneva publie une très forte performance opérationnelle sur les neufs premiers mois de l'exercice 2017 La forte performance opérationnelle sur les neuf premiers mois de l'exercice 2017 et les perspectives annuelles [...]

VALNEVA Reports Strong Operational Performance for the First Nine Months of 2017

09/11/2017 - 07:02

Valneva Reports Strong Operational Performance for the First Nine Months of 2017 Strong financial performance for first nine months of 2017 and full year outlook leads to upward revision of EBITDA guidance Total [...]

ABLYNX TO PRESENT AT UPCOMING INVESTOR CONFERENCES IN LONDON AND PARIS

09/11/2017 - 07:01

GHENT, Belgium, 9 November 2017 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announces that it will participate in the following upcoming investor conferences taking place in London, UK and Paris, France: [...]

Apellis Pharmaceuticals Announces Pricing of Initial Public Offering

09/11/2017 - 03:38

CRESTWOOD, Ky., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (NASDAQ: APLS ), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease [...]

Sarepta Therapeutics Prices $475 Million of Convertible Senior Notes Due 2024

09/11/2017 - 00:45

CAMBRIDGE, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to [...]